Lunch Activity/Non-CE-Accredited Satellite Symposium: Treatment Options for Patients with Resectable and Metastatic Non-Small Cell Lung Cancer <br> Bristol Myers Squibb </br><br><i> Seating available on first-come, first-served basis </br></i>